Showing 16,501 - 16,520 results of 18,566 for search 'significantly ((((mean decrease) OR (((we decrease) OR (a decrease))))) OR (linear decrease))', query time: 0.54s Refine Results
  1. 16501

    Data Sheet 1_Thalamic functional dysconnectivity in patients with left-hemisphere chronic capsular and pontine stroke.pdf by Jun Guo (85069)

    Published 2024
    “…Finally, we found significant group x subfields interactions on thalamic functional connectivity, where capsular vs. pontine stroke demonstrate varied functional dysconnectivity with specific thalamic subfields. …”
  2. 16502

    Trivalent chromium ion removal from synthetic wastewater using graphene oxide nanocollector by various flotation mechanisms by Mohammad Sadatipour (20575527)

    Published 2025
    “…<p>The scarcity of freshwater resources for industrial applications poses a significant global concern. Therefore, wastewater treatment is vital for industrial reuse and decreases environmental damage. …”
  3. 16503

    Loading Thiacorrole with Various Aromatic Rings: Enhanced NIR Absorption and Improved OER Activity by Jiayang Liu (10650926)

    Published 2025
    “…DFT calculation indicates the peripheral annulations reduce the HOMO–LUMO gaps through the significantly decreasing LUMO levels with respect to HOMO levels. …”
  4. 16504

    Presentation 1_Deficits in medial prefrontal cortex parvalbumin expression and distraction-dependent memory in rats and mice in the sub-chronic phencyclidine model for schizophreni... by Katie R. Landreth (22518581)

    Published 2025
    “…TCSI testing showed that scPCP mice expressed diminished sociability overall and increased susceptibility to distraction for social memory, particularly for rearing behavior. There was a significant reduction in PVI density in the scPCP mouse mPFC.…”
  5. 16505

    Care quality. by Youssef Hbid (18803761)

    Published 2025
    “…Stroke multidisciplinary access increased during the first lockdown but decreased in subsequent periods. Access to thrombectomy sequentially increased across time periods; by 40% during first lockdown (adjusted Odd-Ratio: 1.4; 95% CI:1.24–1.58), second lockdown (aOR: 1.77; 1.66–1.92), and 2-folds post-lockdown (aOR: 2.03; 1.92–2.15). …”
  6. 16506

    Outcomes at discharge. by Youssef Hbid (18803761)

    Published 2025
    “…Stroke multidisciplinary access increased during the first lockdown but decreased in subsequent periods. Access to thrombectomy sequentially increased across time periods; by 40% during first lockdown (adjusted Odd-Ratio: 1.4; 95% CI:1.24–1.58), second lockdown (aOR: 1.77; 1.66–1.92), and 2-folds post-lockdown (aOR: 2.03; 1.92–2.15). …”
  7. 16507

    Patient characteristics. by Youssef Hbid (18803761)

    Published 2025
    “…Stroke multidisciplinary access increased during the first lockdown but decreased in subsequent periods. Access to thrombectomy sequentially increased across time periods; by 40% during first lockdown (adjusted Odd-Ratio: 1.4; 95% CI:1.24–1.58), second lockdown (aOR: 1.77; 1.66–1.92), and 2-folds post-lockdown (aOR: 2.03; 1.92–2.15). …”
  8. 16508

    Numerical data and gene lists for all graphs. by Hilary T. Brewis (11798006)

    Published 2025
    “…Furthermore, mapping H2A.Z incorporation before and after treatment with HU revealed that decreases in H2A.Z enrichment at transcription start sites was correlated with, but generally not required for, the upregulation of genes during HU exposure. …”
  9. 16509

    DESeq output data for all comparisons. by Hilary T. Brewis (11798006)

    Published 2025
    “…Furthermore, mapping H2A.Z incorporation before and after treatment with HU revealed that decreases in H2A.Z enrichment at transcription start sites was correlated with, but generally not required for, the upregulation of genes during HU exposure. …”
  10. 16510

    The Type I JAKinib, ruxolitinib, promotes pJAK1 and pJAK2 phosphorylation in MSCs from salivary glands. by Ilya Gurevic (1326786)

    Published 2025
    “…(E-G) were performed with replicates (n = 6; 3 SjD and 3 control) of our treatment conditions on the right with a representative western on the left; (E) pJAK1 proportion increased in a dose-dependent manner with increasing ruxolitnib; (F) pJAK2 proportion increased as ruxolitinib dose increased; (G) pSTAT1 decreased in a dose response relationship with increasing ruxolitinib. …”
  11. 16511

    DataSheet1_Clinical associations of complement-activating collectins, collectin-10, collectin-11 and mannose-binding lectin in preterm neonates.pdf by Gabriela Gajek (4060549)

    Published 2024
    “…COLEC11 heterozygosity for the activity-decreasing polymorphism (rs7567833, +39618 A>G, His219Arg) was more common in preterm premature rupture of membranes (pPROM) cases, compared with corresponding reference groups. …”
  12. 16512

    Table 3_Changes in children respiratory infections pre and post COVID-19 pandemic.docx by Yuanyuan Yue (3226023)

    Published 2025
    “…Background<p>Non-pharmaceutical interventions (NPIs) implemented during the COVID-19 pandemic had a significant impact on the prevalence of various acute respiratory infections (ARIs) pathogens.…”
  13. 16513

    Table 2_Changes in children respiratory infections pre and post COVID-19 pandemic.xlsx by Yuanyuan Yue (3226023)

    Published 2025
    “…Background<p>Non-pharmaceutical interventions (NPIs) implemented during the COVID-19 pandemic had a significant impact on the prevalence of various acute respiratory infections (ARIs) pathogens.…”
  14. 16514

    Table 1_Changes in children respiratory infections pre and post COVID-19 pandemic.xlsx by Yuanyuan Yue (3226023)

    Published 2025
    “…Background<p>Non-pharmaceutical interventions (NPIs) implemented during the COVID-19 pandemic had a significant impact on the prevalence of various acute respiratory infections (ARIs) pathogens.…”
  15. 16515

    Table 6_Global burden of amputation among children and adolescents from 1990 to 2021: systematic analysis of the Global Burden of Disease study 2021.xlsx by Tao Zhang (43681)

    Published 2025
    “…</p>Results<p>We found a global decline in the age-standardized incidence rate (ASIR), age-standardized prevalence rate (ASPR), and age-standardized YLDs rate (ASYR) for children and adolescents. …”
  16. 16516

    Table 3_Global burden of amputation among children and adolescents from 1990 to 2021: systematic analysis of the Global Burden of Disease study 2021.xlsx by Tao Zhang (43681)

    Published 2025
    “…</p>Results<p>We found a global decline in the age-standardized incidence rate (ASIR), age-standardized prevalence rate (ASPR), and age-standardized YLDs rate (ASYR) for children and adolescents. …”
  17. 16517

    Image 11_Global burden of amputation among children and adolescents from 1990 to 2021: systematic analysis of the Global Burden of Disease study 2021.png by Tao Zhang (43681)

    Published 2025
    “…</p>Results<p>We found a global decline in the age-standardized incidence rate (ASIR), age-standardized prevalence rate (ASPR), and age-standardized YLDs rate (ASYR) for children and adolescents. …”
  18. 16518

    Table 1_Global burden of amputation among children and adolescents from 1990 to 2021: systematic analysis of the Global Burden of Disease study 2021.xlsx by Tao Zhang (43681)

    Published 2025
    “…</p>Results<p>We found a global decline in the age-standardized incidence rate (ASIR), age-standardized prevalence rate (ASPR), and age-standardized YLDs rate (ASYR) for children and adolescents. …”
  19. 16519

    Image 9_Global burden of amputation among children and adolescents from 1990 to 2021: systematic analysis of the Global Burden of Disease study 2021.png by Tao Zhang (43681)

    Published 2025
    “…</p>Results<p>We found a global decline in the age-standardized incidence rate (ASIR), age-standardized prevalence rate (ASPR), and age-standardized YLDs rate (ASYR) for children and adolescents. …”
  20. 16520

    Image 13_Global burden of amputation among children and adolescents from 1990 to 2021: systematic analysis of the Global Burden of Disease study 2021.tiff by Tao Zhang (43681)

    Published 2025
    “…</p>Results<p>We found a global decline in the age-standardized incidence rate (ASIR), age-standardized prevalence rate (ASPR), and age-standardized YLDs rate (ASYR) for children and adolescents. …”